Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

People with limited treatment options

HIV Drug Resistance Effect Damped Down over Time

Editor's pick
MedPage Today
10 October 2011
Adherence

Detectable viral load in patients taking HIV therapy associated with poor control of other chronic health problems

News
10 October 2011
Cardiovascular disease

Waist circumference and triglycerides: simple measures of increased cardiovascular risk for patients with HIV

News
10 October 2011
New & experimental HIV treatments

Boehringer signs away HIV rights to focus on hep C - InPharm

Editor's pick
InPharm
7 October 2011
HIV treatment for children & young people

Global survey shows high frequency of resistance after first-line ART failure in children

News
6 October 2011
Pharmaceutical industry

Gilead Sciences inks licensing deal for HIV drug -

Editor's pick
Bloomberg BusinessWeek
6 October 2011
New & experimental hepatitis C treatment

ICAAC: HCV Drug Telaprevir Shows No Problematic Interactions with Raltegravir

Editor's pick
HIVandhepatitis.com
6 October 2011
Global health initiatives

PEPFAR is poised to get on track to end AIDS

Editor's pick
Science Speaks
5 October 2011
HIV treatment for children & young people

Efavirenz may be under-dosed in children

News
5 October 2011
Treatment outcomes & life expectancy

Uncontrolled viral load increases risk of AIDS for patients with a CD4 cell count above 350

News
3 October 2011
New & experimental HIV treatments

Behind the headlines: HIV vaccine passes phase I trial

Editor's pick
NHS Choices
30 September 2011
Hepatitis C treatment

Hepatitis C patients likely to falter in adherence to treatment regimen over time, Penn study shows

Editor's pick
Eurekalert Medicine & Health
29 September 2011
The search for an HIV prevention vaccine

HIV vaccine is a small breakthrough, but not a cure

Editor's pick
The Guardian
29 September 2011
PrEP science

Tenofovir PrEP arm dropped in women's HIV prevention trial

News
29 September 2011
New & experimental HIV treatments

Biotron begins landmark phase 1b/2a human trial for HIV drug

Editor's pick
Business Spectator
29 September 2011
Circumcision

Top economists say circumcision not best anti-HIV tactic

Editor's pick
USA Today
29 September 2011
Starting treatment

Point-of-care CD4 test improves retention and treatment initiation in Mozambique

News
28 September 2011
Finance & funding

Haiti: Early HIV treatment cost-effective in one of the world's poorest countries

News
28 September 2011
Viral load

Missed appointments in early years of HIV care associated with longer time to HIV suppression and higher cumulative viral load

News
28 September 2011
Treatment outcomes & life expectancy

Older age and immune response to CMV affect CD4 cell recovery after starting HIV therapy

News
27 September 2011
Treatment outcomes & life expectancy

HIV treatment at 500 CD4 level would put half of patients in need of ART within a year of seroconversion

News
26 September 2011
Starting treatment

Beliefs about efficacy of HIV treatment predict which urban poor patients start antiretroviral therapy

News
26 September 2011
New & experimental HIV treatments

Off-Label Use of HIV Medications Is Catalyst for More Controversy

Editor's pick
New York Times
24 September 2011
Treatment outcomes & life expectancy

ICAAC: One-Pill HIV Regimen Tied to Less Inpatient Care

Editor's pick
MedPage Today HIV/AIDS
23 September 2011